...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Synthesis and structure-activity relationship studies of novel [6,6,5] tricyclic oxazolidinone derivatives as potential antibacterial agents
【24h】

Synthesis and structure-activity relationship studies of novel [6,6,5] tricyclic oxazolidinone derivatives as potential antibacterial agents

机译:新型[6,6,5]三环恶唑烷酮衍生物作为潜在抗菌剂的合成及构效关系研究

获取原文
获取原文并翻译 | 示例
           

摘要

In our previous Letter, we reported the discovery of a novel benzoxazinyl-oxazolidinone antibacterial candidate 2. In order to identify a potential backup compound, extensive modifications on the B/C ring and C3 side chain were undertaken. A series of novel [6,6,5] tricyclic analogues were synthesized and their in vitro antibacterial activities were tested against a panel of susceptible and resistant Gram-positive pathogens. Among of them, benzothiazinyl-oxazolidinones with acetamide or thioamide as C3 side chains exhibited moderate to good antibacterial activity, such as compounds 54, 58, 59 and 63. In vitro liver microsomal stability was further evaluated and the results manifested that compounds 54 and 58 were both metabolically stable in rat and human liver microsomes. Additionally, insights gained from this investigation should provide directions for the further research of new oxazolidinone antibiotics. (C) 2015 Elsevier Ltd. All rights reserved.
机译:在我们的前一封信中,我们报告了新型苯并恶嗪基-恶唑烷酮抗菌候选物2的发现。为了鉴定潜在的备用化合物,对B / C环和C3侧链进行了广泛的修饰。合成了一系列新颖的[6,6,5]三环类似物,并针对一组敏感和耐药的革兰氏阳性病原体测试了它们的体外抗菌活性。其中,以乙酰胺或硫酰胺作为C3侧链的苯并噻嗪基-恶唑烷酮类化合物表现出中等至良好的抗菌活性,例如化合物54、58、59和63。进一步评估了体外肝微粒体的稳定性,结果表明化合物54和58在大鼠和人肝微粒体中代谢均稳定。此外,从这项调查中获得的见识应为新的恶唑烷酮抗生素的进一步研究提供指导。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号